Kaylee Slater

Ms. Kaylee Slater

University of Newcastle, Australia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Kaylee SlaterKaylee Slater
Kaylee Slater
MRMegan Rollo
Megan Rollo
ZSZoe Szewczyk
Zoe Szewczyk
LALee Ashton
Lee Ashton
Tracy SchumacherTracy Schumacher
Tracy Schumacher
CCClare Collins
Clare Collins
The maternal diet influences the long-term health status of both mother and offspring. The current study aimed to compare dietary intakes of pregnant women compared to food and nutrient recommendations in the Australian Guide to Healthy Eating (AGHE) and Nutrient Reference Values (NRVs). Usual dietary intake was assessed in a sample of women in their 3rd trimester of pregnancy attending antenatal outpatient clinics at John Hunter Hospital, Newcastle, New South Wales (NSW). Dietary intake was measured using the Australian Eating Survey, a validated, semi-quantitative 120-item food frequency questionnaire. Daily food group servings and nutrient intakes were compared to AGHE and NRV targets. Of 534 women participating, none met the AGHE recommendations for all food groups. Highest adherence was for fruit serves (38%), and lowest for breads and cereals (0.6%). Only four women met the pregnancy NRVs for folate, iron, calcium, zinc and fibre from food alone. Current dietary intakes of Australian women during pregnancy do not align with national nutrition guidelines. This highlights the importance of routine vitamin and mineral supplementation during pregnancy, as intakes from diet alone may commonly be inadequate. Future revisions of dietary guidelines and pregnancy nutrition recommendations should consider current dietary patterns. Pregnant women currently need more support to optimise food and nutrient intakes.

Verified
Journal Article
Open access
PDF file
ETEleanor P Thong
Eleanor P Thong
DGDrishti Ghelani
Drishti Ghelani
PMPamada Manoleehakul
Pamada Manoleehakul
AYAnika Yesmin
Anika Yesmin
Kaylee SlaterKaylee Slater
Kaylee Slater
JEJoanne Enticott
Joanne Enticott
Cardiovascular disease, especially coronary heart disease and cerebrovascular disease, is a leading cause of mortality and morbidity in women globally. The development of cardiometabolic conditions in pregnancy, such as gestational diabetes mellitus and hypertensive disorders of pregnancy, portend an increased risk of future cardiovascular disease in women. Pregnancy therefore represents a unique opportunity to detect and manage risk factors, prior to the development of cardiovascular sequelae. Risk prediction models for gestational diabetes mellitus and hypertensive disorders of pregnancy can help identify at-risk women in early pregnancy, allowing timely intervention to mitigate both short- and long-term adverse outcomes. In this narrative review, we outline the shared pathophysiological pathways for gestational diabetes mellitus and hypertensive disorders of pregnancy, summarise contemporary risk prediction models and candidate predictors for these conditions, and discuss the utility of these models in clinical application.

31 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Kaylee SlaterKaylee Slater
Kaylee Slater
RTRachael Taylor
Rachael Taylor
KMKaren McLaughlin
Karen McLaughlin
CPCraig Pennell
Craig Pennell
CCClare Collins
Clare Collins
Melinda HutchessonMelinda Hutchesson
Melinda Hutchesson
Women with a history of hypertensive disorders of pregnancy (HDP) have an increased risk of cardiovascular disease (CVD). Guidelines recommend that women diagnosed with HDP should be advised of their increased CVD risk, have regular blood pressure monitoring by their general practitioner (GP), and adopt healthy lifestyle behaviours. However, within Australia, the current practice in primary health care is unknown. The aim of this study was to describe current practices, barriers, and facilitators to the provision of CVD preventative services for women after HDP in the primary care setting and to identify potential strategies to support GPs in providing recommended care. Separate cross-sectional online surveys were undertaken with 35 GPs and 105 women with a history of HDP. Surveys included both closed- and open-ended questions. Closed-ended questions were analysed using basic descriptive statistics, and open-ended questions were themed and tallied. The survey of GPs revealed that GPs are more likely to assess traditional CVD risk markers than lifestyle risk factors or HDP history. GPs identified a lack of resources and skills as barriers to providing CVD preventative care post-HDP. The survey with women after HDP revealed that women with a history of HDP are more likely to be assessed for blood pressure than lifestyle CVD risk factors, and that the women’s barriers to obtaining care included difficulty obtaining an appointment and time required for attending appointments. Strategies to improve CVD preventative care were consistent between surveys, where 70% of GPs and 59% of women chose ‘increasing women’s awareness of increased CVD risk’ and 67% of GPs and 55% of women chose ‘improving communication between hospitals and primary care’ as their preferred strategies. While the findings suggest that women with a history of HDP are receiving advice consistent with guidelines for traditional CVD risk markers, such as blood pressure, they are less likely to receive CVD preventative care for lifestyle or female-specific CVD risk factors.

13 January 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Kaylee SlaterKaylee Slater
Kaylee Slater
Tracy SchumacherTracy Schumacher
Tracy Schumacher
KDKer Nee Ding
Ker Nee Ding
RTRachael Taylor
Rachael Taylor
VSVanessa Shrewsbury
Vanessa Shrewsbury
Melinda HutchessonMelinda Hutchesson
Melinda Hutchesson
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in women. Hypertensive disorders of pregnancy (HDP) affect 5–10% of pregnancies worldwide, and are an independent risk factor for CVD. A greater understanding of the rates of modifiable CVD risk factors in women with a history of HDP can inform CVD prevention priorities in this group. The aim of this study was to understand the rates of individual and multiple modifiable risk factors for CVD (body mass index, fruit and vegetable intake, physical activity, sitting time, smoking, alcohol consumption and depressive symptoms) among women with a history of HDP, and assess whether they differ to women without a history of HDP. This study is a cross-sectional analysis of self-reported data collected for the Australian Longitudinal Study of Women’s Health (ALSWH). The sample included 5820 women aged 32–37 years old, who completed survey 7 of the ALSWH in 2015. Women with a history of HDP had a higher multiple CVD modifiable risk factor score compared to those without HDP (mean (SD): 2.3 (1.4) vs. 2.0 (1.3); p < 0.01). HDP history was significantly associated with a higher body mass index (p < 0.01), high-risk alcohol consumption (p = 0.04) and more depressive symptoms (p < 0.01). Understanding that women with a history of HDP have higher CVD risk factors, specifically body mass index, alcohol consumption and depressive symptoms, allows clinicians to provide appropriate and tailored CVD interventions for this group of women.

20 February 2025 in Health Research Policy and Systems
Verified
Journal Article
Open access
PDF file
Kaylee SlaterKaylee Slater
Kaylee Slater
RTRachael Taylor
Rachael Taylor
KMKaren McLaughlin
Karen McLaughlin
CPCraig E. Pennell
Craig E. Pennell
KFKaryn Forbes
Karyn Forbes
MHMelinda Hutchesson
Melinda Hutchesson
Background: Women with a history of hypertensive disorders of pregnancy are at an increased risk of cardiovascular disease. Although clinical practice guidelines for management of hypertensive disorders of pregnancy recommend involvement of a general practitioner for ongoing cardiovascular disease preventative care, there are no intervention strategies embedded within primary care aimed at improving risk assessment or management for women after hypertensive disorders of pregnancy. The study aim was to co-design an intervention to improve implementation of cardiovascular disease risk assessment and management following hypertensive disorders of pregnancy for primary care settings in a local health district in New South Wales, Australia. Method: Using the Integrated Knowledge Translation framework, a series of five co-design meetings with the investigative team and end users were conducted online. Meetings were informed by the Behaviour Change Wheel framework for intervention development and incorporated research findings from a systematic review and meta-analysis, surveys and an online discussion. Data from activities and audio recordings following each meeting were analysed thematically using inductive–deductive thematic analysis. Results were summarized after each meeting, and findings used to inform ongoing intervention development. Results: The 18 end users included women with lived experience of hypertensive disorders of pregnancy (n = 8), obstetricians (n = 2), midwives (n = 5) and general practitioners (n = 3). Target priorities were to improve communication between hospital staff and general practitioners following the occurrence of hypertensive disorders of pregnancy and increase the knowledge of general practitioners and women regarding cardiovascular disease prevention after cardiometabolic pregnancy complications. Part 1 of the intervention is set within the hospital setting and delivered via physical resources to address the communication gap between hospital and primary care providers about the occurrence of hypertensive disorders of pregnancy. Part 2 is delivered via an update to an existing general practice education platform and through resources for use within consultations to provide education for women and general practitioners about cardiovascular disease prevention after hypertensive disorders of pregnancy. Conclusion: The Integrated Knowledge Translation and Behaviour Change Wheel frameworks aided in the development of a targeted intervention to improve implementation of cardiovascular risk assessment and management for women after hypertensive disorders of pregnancy, based on gaps identified in current primary care practice.

3 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ECEleanor Clapham
Eleanor Clapham
SCSamuel Carmichael
Samuel Carmichael
DPDean Picone
Dean Picone
Aletta SchutteAletta Schutte
Aletta Schutte
Kaylee SlaterKaylee Slater
Kaylee Slater
NCNiamh Chapman
Niamh Chapman
Background: Only 10-20% of blood pressure (BP) devices available are validated. Little is known about how and why patients choose BP devices for home BP measurement (HBPM), which was the aim of this study. Methods: Mixed-methods study (online survey (n=241), phone interviews among a purposive subsample (n=27)) among adults who perform HBPM in Australia (June-Dec 2023). Survey questions determined how BP devices were obtained, device make/model and factors influencing device selection. Interviews further explored these topics. Device validation status was determined using the STRIDE BP and Medaval websites. Results: Participants were middle aged (58±16 years, 52% women) and 91% purchased a device for HBPM (n=189; 9% borrowed a device), with 69% (n=130) purchased from pharmacies (53% validated) and 21% (n=39) purchased online (51% validated). Accuracy was said to be the most important consideration when choosing a device for most participants (n=129, 77%). Interview participants described using brand recognition, online reviews and cost to select an ‘accurate’ device; avoiding cheaper devices and preferring brands used in healthcare settings. Participants did not consider validation status and did not receive advice on device accuracy at point-of-sale. Conclusion: This study highlights real world experiences of adults when obtaining HBPM devices that can be used to inform strategies to direct adults to validated devices. Strategies such as increasing signage at the point-of-sale and training healthcare practitioners to identify and direct consumers to validated devices may be effective in increasing uptake. Regulatory bodies should mandate the sale of validated devices in healthcare settings to increase availability. GRAPHICAL